
The direct oral factor Xa inhibitor edoxaban was found to be noninferior to well-managed warfarin for preventing strokes or systemic embolism in patients with atrial fibrillation.

The direct oral factor Xa inhibitor edoxaban was found to be noninferior to well-managed warfarin for preventing strokes or systemic embolism in patients with atrial fibrillation.

Letters, e-mails, Facebook posts, and web comments from Drug Topics readers.

This year’s flu season has been hard on young and middle-aged adults, with most hospitalizations involving patients 18 to 64 years old.

All pregnant women should be screened for gestational diabetes mellitus at 24 weeks gestation, even if they have no symptoms, according to new recommendations from the USPSTF.

Drug shortages are causing medication errors, delayed or cancelled care, and prompting patient complaints, according to a survey of pharmacy directors published in the Journal of Managed Care Pharmacy.

GSK's Mekinist and Tafinlar combination received accelerated approval after priority review.

Now you see it, now you don't . . . the big pharmacy school con

The view from another zoo.

When the cure is killing you, what's wrong with using a drug that actually helps you feel better - and maybe stay alive?

One chain used the legal system to tell its pharmacists how it really felt. They got the message.

NABP effort seeks worldwide protection for consumers and users of pharmacies online.

As hospitals face decreased reimbursements, pharmacist involvement in pre- and post-discharge medication reconciliation is more important than ever.

The law expands the powers of registered pharmacists and establishes a new category of Advanced Practice Pharmacists.

Patch treating overactive bladder in women is now available OTC.

Since the NECC-triggered outbreak of fungal meningitis in 2012, FDA has responded aggressively, inspected almost 70 pharmacies. Now it is supported by a new law, the DQSA, and many new questions arise.

Portola is pursuing accelerated approval for andexanet alfa and plans to initiate studies on a larger scale in 2014.

Three states prepare to handle mushrooming Medicaid enrollments

Some of the medications coming into Maine will originate in countries where oversight of the pharmaceutical production process is lax or nil. Are the possible consequences worth the probable savings?

The U.S. Drug Enforcement Administration is investigating pseudoephedrine sales at Rite Aid stores throughout West Virginia, according to a published report.

FDA has issued a warning that over-the-counter sodium phosphate drugs can cause serious injury to kidneys and the heart if more than one dose is taken in 24 hours.

A survey of more than 1,000 pharmacists conducted by NCPA reveals high numbers of chronic-pain patients who had to wait or search to fill their prescriptions and pharmacies without supplies to fill them at all.

Two big causes drive NCPA's new president.


Members of the American Pharmacists Association (APhA) will meet the 2014 president-elect candidates during the APhA annual meeting and exhibition in Orlando in March.

NCPA has asked congressional leaders to look into the reasons behind the skyrocketing costs of generic drugs.